AL-15469A [moxifloxacin] for the treatment of bacterial conjunctivitis.

Trial Profile

AL-15469A [moxifloxacin] for the treatment of bacterial conjunctivitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2012

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial infections; Infectious conjunctivitis
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 02 Mar 2012 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
    • 06 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top